Tag Archive for: financing

Ruben de Francisco, Founder & CEO Onera Health. © Onera Health NV

Sleep diagnostics specialist Onera Health NV has closed a €30m (US$32m) Series C financing round co-led by EQT Life Sciences and Gimv.

© Enifer

Microbial production specialist Enifer has secured a €12m grant from Business Finland to build a mycoprotein ingredient factory with a capacity of 300,000 tonnes annually.

Mogu Panels are made from soft, foam-like mycelium materials and of upcycled textile residues. © Mogu Srl

Italian mycelium specialist Mogu Srl has closed a €11m Series A financing co-led by CDP Venture Capital and the  European Circular Bioeconomy Fund (ECBF VC)

Antibiotic resistance tests; the bacteria in the culture on the left are sensitive to the antibiotics contained in the white paper discs. The bacteria on the right are resistant to most of the antibiotics. © Dr Graham Beards  wikipedia.org

Novo Nordisk Foundation has partnered with CARB-X investing US$25m to help SMEs to fight drug-resistant infections.

Brown and white fat cells. © Patrick Seale, University of Pennsylvania School of Medicine/NIH

Italian Resalis Therapeutics Srl has baged €10m in a Series A financing led by Sunstone Life Science Ventures to complete a Phase I study for RES-010 in obesity.

In 2021, Metrion Biosciences moved into its labs in Cambridge, UK. © Metrion Biosciences Ltd

Cambridge-based Metrion Biosciences Ltd has secured £3.5m in new equity financing – led by Maven Capital Partners and a £1m contribution from existing investor, Gresham House Ventures.

Picture: © Cohesion Bureau

Continuing geopolitical uncertainty has perpetuated volatility in global markets, exacerbated by higher inflation and interest rates. The impact has left the biotech market in a limbo as investors eschew riskier investments, but there are signs of a potential recovery ahead.

Aerial view at EFPL where the technology was established. © EFPL

Lausanne-based Vandria SA has cashed in CHF18m in a Series A financing led by ND Capital to drive clinical development of VNA-318.

© Nature Design - pixabay.com

Antibiotics specialist Antabio SAS has raised €25m in a Series B financing round with subscriptions from the AMR Action Fund, the EIC Fund and from existing investors.

Carthera SA

Sorbonne University spin-out Carthera SA has closed its Series B financing round with an additional investment of €4.5m at €42m to launch clinical trials.